News & Views
Laboratory scientists use silica to boost cancer-killing antibodies
May 24 2010
In collaboration with the University of Washington, the researchers found that packaging anti-cancer drugs into particles of chemically-modified silica cages helped the treatments to be more effective.
Published in the Journal of the American Chemical Society, the findings could mean that taking pills to battle cancer in humans could be replaced by an intravenous drip of the modified particles.
Chenghong Lei from the PNNL said: "We are very excited by our preliminary results. We plan to do some additional, larger studies with animals. We hope the results hold up well enough to take it to clinical trials."
DKFZ scientists in Sweden recently revealed that people with type-2 diabetes could have an increased risk of developing cancer, especially in the liver and pancreas, although they also may have a reduced chance of contracting prostate cancer.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK